431 related articles for article (PubMed ID: 24302614)
1. CHIP/Stub1 functions as a tumor suppressor and represses NF-κB-mediated signaling in colorectal cancer.
Wang Y; Ren F; Wang Y; Feng Y; Wang D; Jia B; Qiu Y; Wang S; Yu J; Sung JJ; Xu J; Zeps N; Chang Z
Carcinogenesis; 2014 May; 35(5):983-91. PubMed ID: 24302614
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of
Jiao HL; Ye YP; Yang RW; Sun HY; Wang SY; Wang YX; Xiao ZY; He LQ; Cai JJ; Wei WT; Chen YR; Gu CC; Cai YL; Hu YT; Lai QH; Qiu JF; Liang L; Cao GW; Liao WT; Ding YQ
Clin Cancer Res; 2017 Nov; 23(22):7108-7118. PubMed ID: 28912140
[No Abstract] [Full Text] [Related]
3. The ubiquitin ligase CHIP inactivates NF-κB signaling and impairs the ability of migration and invasion in gastric cancer cells.
Liu F; Zhou J; Zhou P; Chen W; Guo F
Int J Oncol; 2015 May; 46(5):2096-106. PubMed ID: 25672477
[TBL] [Abstract][Full Text] [Related]
4. CHIP functions as an oncogene by promoting colorectal cancer metastasis via activation of MAPK and AKT signaling and suppression of E-cadherin.
Xu J; Zhou J; Dai H; Liu F; Li W; Wang W; Guo F
J Transl Med; 2018 Jun; 16(1):169. PubMed ID: 29921293
[TBL] [Abstract][Full Text] [Related]
5. CHIP functions as a novel suppressor of tumour angiogenesis with prognostic significance in human gastric cancer.
Wang S; Wu X; Zhang J; Chen Y; Xu J; Xia X; He S; Qiang F; Li A; Shu Y; Røe OD; Li G; Zhou JW
Gut; 2013 Apr; 62(4):496-508. PubMed ID: 22535373
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin ligase CHIP induces TRAF2 proteasomal degradation and NF-κB inactivation to regulate breast cancer cell invasion.
Jang KW; Lee KH; Kim SH; Jin T; Choi EY; Jeon HJ; Kim E; Han YS; Chung JH
J Cell Biochem; 2011 Dec; 112(12):3612-20. PubMed ID: 21793045
[TBL] [Abstract][Full Text] [Related]
7. RNF183 promotes proliferation and metastasis of colorectal cancer cells via activation of NF-κB-IL-8 axis.
Geng R; Tan X; Wu J; Pan Z; Yi M; Shi W; Liu R; Yao C; Wang G; Lin J; Qiu L; Huang W; Chen S
Cell Death Dis; 2017 Aug; 8(8):e2994. PubMed ID: 28796265
[TBL] [Abstract][Full Text] [Related]
8. A microRNA 221- and 222-mediated feedback loop maintains constitutive activation of NFκB and STAT3 in colorectal cancer cells.
Liu S; Sun X; Wang M; Hou Y; Zhan Y; Jiang Y; Liu Z; Cao X; Chen P; Liu Z; Chen X; Tao Y; Xu C; Mao J; Cheng C; Li C; Hu Y; Wang L; Chin YE; Shi Y; Siebenlist U; Zhang X
Gastroenterology; 2014 Oct; 147(4):847-859.e11. PubMed ID: 24931456
[TBL] [Abstract][Full Text] [Related]
9. Loss of RNF40 Decreases NF-κB Activity in Colorectal Cancer Cells and Reduces Colitis Burden in Mice.
Kosinsky RL; Chua RL; Qui M; Saul D; Mehlich D; Ströbel P; Schildhaus HU; Wegwitz F; Faubion WA; Johnsen SA
J Crohns Colitis; 2019 Mar; 13(3):362-373. PubMed ID: 30321325
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis.
Lu YX; Ju HQ; Wang F; Chen LZ; Wu QN; Sheng H; Mo HY; Pan ZZ; Xie D; Kang TB; Chen G; Yun JP; Zeng ZL; Xu RH
Cancer Lett; 2016 Sep; 380(1):87-97. PubMed ID: 27322737
[TBL] [Abstract][Full Text] [Related]
11. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
12. SUB1 promotes colorectal cancer metastasis by activating NF-κB signaling via UBR5-mediated ubiquitination of UBXN1.
Wang H; Chen W; Wang Y; Gao Y; Zhang Z; Mi S; Wang L; Xue M
Sci China Life Sci; 2024 Jun; 67(6):1199-1211. PubMed ID: 38240906
[TBL] [Abstract][Full Text] [Related]
13. Heat shock protein 90 promotes epithelial to mesenchymal transition, invasion, and migration in colorectal cancer.
Nagaraju GP; Long TE; Park W; Landry JC; Taliaferro-Smith L; Farris AB; Diaz R; El-Rayes BF
Mol Carcinog; 2015 Oct; 54(10):1147-58. PubMed ID: 24861206
[TBL] [Abstract][Full Text] [Related]
14. Associations among beta-TrCP, an E3 ubiquitin ligase receptor, beta-catenin, and NF-kappaB in colorectal cancer.
Ougolkov A; Zhang B; Yamashita K; Bilim V; Mai M; Fuchs SY; Minamoto T
J Natl Cancer Inst; 2004 Aug; 96(15):1161-70. PubMed ID: 15292388
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer cell intrinsic fibroblast activation protein alpha binds to Enolase1 and activates NF-κB pathway to promote metastasis.
Yuan Z; Hu H; Zhu Y; Zhang W; Fang Q; Qiao T; Ma T; Wang M; Huang R; Tang Q; Gao F; Zou C; Gao X; Wang G; Wang X
Cell Death Dis; 2021 May; 12(6):543. PubMed ID: 34035230
[TBL] [Abstract][Full Text] [Related]
16. LPS Upregulated VEGFR-3 Expression Promote Migration and Invasion in Colorectal Cancer via a Mechanism of Increased NF-κB Binding to the Promoter of VEGFR-3.
Zhu G; Huang Q; Zheng W; Huang Y; Hua J; Yang S; Zhuang J; Wang J; Chang J; Xu J; Ye J
Cell Physiol Biochem; 2016; 39(5):1665-1678. PubMed ID: 27639612
[TBL] [Abstract][Full Text] [Related]
17. Olfactomedin 1 negatively regulates NF-κB signalling and suppresses the growth and metastasis of colorectal cancer cells.
Shi W; Ye Z; Zhuang L; Li Y; Shuai W; Zuo Z; Mao X; Liu R; Wu J; Chen S; Huang W
J Pathol; 2016 Nov; 240(3):352-365. PubMed ID: 27555280
[TBL] [Abstract][Full Text] [Related]
18. p53 controls colorectal cancer cell invasion by inhibiting the NF-κB-mediated activation of Fascin.
Sui X; Zhu J; Tang H; Wang C; Zhou J; Han W; Wang X; Fang Y; Xu Y; Li D; Chen R; Ma J; Jing Z; Gu X; Pan H; He C
Oncotarget; 2015 Sep; 6(26):22869-79. PubMed ID: 26362504
[TBL] [Abstract][Full Text] [Related]
19. RASSF8 regulates progression of cutaneous melanoma through nuclear factor-κb.
Wang J; Hua W; Huang SK; Fan K; Takeshima L; Mao Y; Hoon DS
Oncotarget; 2015 Oct; 6(30):30165-77. PubMed ID: 26334503
[TBL] [Abstract][Full Text] [Related]
20. SREBP1 promotes the invasion of colorectal cancer accompanied upregulation of MMP7 expression and NF-κB pathway activation.
Gao Y; Nan X; Shi X; Mu X; Liu B; Zhu H; Yao B; Liu X; Yang T; Hu Y; Liu S
BMC Cancer; 2019 Jul; 19(1):685. PubMed ID: 31299935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
